FDA approves Alexion’s Soliris to treat adults with neuromyelitis optica spectrum disorder

Image: The FDA has approved Alexion’s Soliris to treat adults with neuromyelitis optica spectrum disorder. Photo: courtesy of moritz320 from Pixabay.